Condition: Community-acquired Pneumonia · Sponsor: Shanghai SIMR Biotechnology Co., Ltd.
This is a phase 2 study to evaluate the efficacy and safety of SR1375 in hospitalized adult patients with CAP. Patients will receive SR1375 or placebo for 8 weeks. The study duration for each patient is up to 10 weeks.
This description comes directly from the study's public registry record.
Wang, PhD · (086)021-68161783 · fwang@simrbio.com
Always discuss trial participation with your own doctor first.
| Fuyang People's Hospital | Fuyang, Anhui, China | Recruiting |
| Peking University Third Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Zhangzhou Hospital | Zhangzhou, Fujian, China | Recruiting |
| Gaozhou People's Hospital | Gaozhou, Guangdong, China | Recruiting |
| The First Affiliated Hospital of Sun Yat-sen University | Guangzhou, Guangdong, China | Recruiting |
| The Third Affiliated Hospital of Southern Medical University | Guangzhou, Guangdong, China | Recruiting |
| Nanfang Hospital | Guangzhou, Guangdong, China | Recruiting |
| The First Affiliated Hospital of Shantou University Medical College | Shantou, Guangdong, China | Recruiting |
| Yulin First People's Hospital | Yulin, Guangxi, China | Recruiting |
| The First Hospital of Hebei Medical University | Shijiazhuang, Hebei, China | Recruiting |
| Daqing Longnan Hospital | Daqing, Heilongjiang, China | Recruiting |
| Daqing People's Hospital | Daqing, Heilongjiang, China | Recruiting |
+ 17 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06577558